Smartleaf Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$562K Hold
6,165
0.02% 528
2026
Q1
$490K Buy
6,165
+203
+3% +$16.7K 0.02% 536
2025
Q4
$514K Buy
5,962
+222
+4% +$18.2K 0.02% 522
2025
Q3
$443K Buy
5,740
+1,398
+32% +$109K 0.03% 503
2025
Q2
$340K Sell
4,342
-383
-8% -$28.6K 0.03% 449
2025
Q1
$335K Sell
4,725
-1,064
-18% -$76.2K 0.03% 444
2024
Q4
$430K Buy
5,789
+797
+16% +$55.8K 0.04% 358
2024
Q3
$332K Buy
4,992
+1,576
+46% +$115K 0.04% 362
2024
Q2
$319K Buy
3,416
+1,913
+127% +$169K 0.05% 306
2024
Q1
$143K Buy
1,503
+1,119
+291% +$94K 0.03% 437
2023
Q4
$28.2K Buy
+384
New +$26.7K 0.01% 623

Other funds holding EW

Smartleaf Asset Management's EW Position: Q2 2026 in Review

Smartleaf Asset Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 6,165 shares worth $562K. The position accounts for 0.02% of the portfolio, ranked #528.

Smartleaf Asset Management first reported a position in EW in Q4 2023 and has held it in 11 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Smartleaf Asset Management held 6,165 shares of Edwards Lifesciences worth $562K as of Q2 2026.
  • Smartleaf Asset Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.02% of Smartleaf Asset Management's portfolio in Q2 2026, its #528 holding.
  • Smartleaf Asset Management first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.